Something simple: "I have a prescription injectable medication and a medical cooling case they're medically necessary." Most interactions end there
INTRODUCTION Approximately 25% of HF patients overall and 40% of hospitalized HF patients have DM [3,4,18]
Following GLP-1 deprescription, patients weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to two thirds of weight loss after discontinuing the drug
There are several categories of GLP-1 medications, including tirzepatides (such as Mounjaro and Zepbound), semaglutides (such as Ozempic and Wegovy) and liraglutides (such as Saxenda and Victoza)
The clinician determines what may be appropriate for your situation, which affects what you are offered
Very common side effects of Wegovy include: These side effects usually go away over time as your body gets used to the medication